77 related articles for article (PubMed ID: 20617549)
41. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
42. The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study.
Yadav P; Mir R; Nandi K; Javid J; Masroor M; Ahmad I; Zuberi M; Kaza R; Jain S; Khurana N; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2016; 17(3):1215-9. PubMed ID: 27039751
[TBL] [Abstract][Full Text] [Related]
43. Message about hormone replacement therapy is unclear.
Dixon JM
BMJ; 2002 Nov; 325(7371):1036. PubMed ID: 12411373
[No Abstract] [Full Text] [Related]
44. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
45. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
[TBL] [Abstract][Full Text] [Related]
46. Environmental pollutants and breast cancer.
Townson SM
Cancer Invest; 2004; 22(3):474-6. PubMed ID: 15493368
[No Abstract] [Full Text] [Related]
47. DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India.
Devi KR; Ahmed J; Narain K; Mukherjee K; Majumdar G; Chenkual S; Zonunmawia JC
Technol Cancer Res Treat; 2017 Dec; 16(6):1150-1159. PubMed ID: 29332455
[TBL] [Abstract][Full Text] [Related]
48. Candidate gene-environment interactions in breast cancer.
Fletcher O; Dudbridge F
BMC Med; 2014 Oct; 12():195. PubMed ID: 25604189
[TBL] [Abstract][Full Text] [Related]
49. OX40 genetic variations in patients with breast cancer: a case-control study.
Faghih Z; Taherifard E; Daneshmand A; Talei A; Erfani N
Br J Biomed Sci; 2021 Jan; 78(1):44-46. PubMed ID: 32921275
[No Abstract] [Full Text] [Related]
50. Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer.
Neven P; Jongen L; Van Asten K; Berteloot P; Floris G; Wildiers H
Ann Oncol; 2015 Feb; 26(2):437-8. PubMed ID: 25403581
[No Abstract] [Full Text] [Related]
51. Hormone replacement therapy: a promoter and modulator of breast cancer.
Winchester DJ
Ann Surg Oncol; 2004 Jan; 11(1):9-10. PubMed ID: 14699026
[No Abstract] [Full Text] [Related]
52. [Genetic variations of a tumor].
Yazdi AS
Hautarzt; 2012 Jul; 63(7):587-8. PubMed ID: 22733243
[No Abstract] [Full Text] [Related]
53. Empirical evaluation of gene and environment interactions: methods and potential.
Prentice RL
J Natl Cancer Inst; 2011 Aug; 103(16):1209-10. PubMed ID: 21791675
[No Abstract] [Full Text] [Related]
54. On not being the "hostess with the mostest".
Sledge GW
Clin Breast Cancer; 2004 Aug; 5(3):171. PubMed ID: 15335447
[No Abstract] [Full Text] [Related]
55. Violence--a noxious cocktail of genes and the environment.
Moosajee M
J R Soc Med; 2003 May; 96(5):211-4. PubMed ID: 12724428
[No Abstract] [Full Text] [Related]
56. Predisposition and Environment.
Mills GA
Int Dent J (Phila); 1901 Feb; 22(2):85-88. PubMed ID: 37912844
[No Abstract] [Full Text] [Related]
57. Association between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis.
Li Q; Guan R; Qiao Y; Liu C; He N; Zhang X; Jia X; Sun H; Yu J; Xu L
Oncotarget; 2017 Jun; 8(24):39818-39832. PubMed ID: 28418854
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients.
Wei J; Han B; Mao XY; Wei MJ; Yao F; Jin F
Tumour Biol; 2012 Apr; 33(2):413-20. PubMed ID: 21922275
[TBL] [Abstract][Full Text] [Related]
59. Genes, the environment, and breast cancer.
Narod SA
Lancet; 2010 Jun; 375(9732):2123-4. PubMed ID: 20617549
[No Abstract] [Full Text] [Related]
60. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
